Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-12

Clinical Trial Update: Cilostazol Following Peripheral Endovascular Procedures [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for cilostazol following peripheral endovascular procedures in peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilostazol (Cilostazol)

Snippet

Sponsor: Attikon Hospital | Conditions: Peripheral Arterial Disease | Phase 3 | Status: UNKNOWN